These findings identify a critical immunometabolic axis—TXNRD1–Nrf2–PD-L1—that mediates both ferroptosis resistance and immune checkpoint blockade failure in HNSCC. The gene discussed is NFE2L2; the disease is head and neck squamous cell carcinoma.